180 related articles for article (PubMed ID: 26886814)
1. Effect of stents coated with a combination of sirolimus and alpha-lipoic acid in a porcine coronary restenosis model.
Lim KS; Park JK; Jeong MH; Bae IH; Nah JW; Park DS; Kim JM; Kim JH; Lee SY; Jang EJ; Jang S; Kim HK; Sim DS; Park KH; Hong YJ; Ahn Y; Kang JC
J Mater Sci Mater Med; 2016 Apr; 27(4):66. PubMed ID: 26886814
[TBL] [Abstract][Full Text] [Related]
2. Comparable vascular response of a new generation sirolimus eluting stents when compared to fluoropolymer everolimus eluting stents in the porcine coronary restenosis model.
Buszman PP; Michalak MJ; Pruski M; Fernandez C; Jelonek M; Janas A; Savard C; Gwiazdowska-Nowotka B; Żurakowski A; Wojakowski W; Buszman PE; Milewski K
Cardiol J; 2016; 23(6):657-666. PubMed ID: 27976797
[TBL] [Abstract][Full Text] [Related]
3. Dose-dependent vascular response following delivery of sirolimus via fast releasing, biodegradable polymer stent matrix: an experimental study in the porcine coronary model of restenosis.
Buszman PP; Orlik B; Pająk J; Jelonek M; Krauze A; Janas A; Legutko J; Wojakowski W; Buszman PE; Milewski K
Kardiol Pol; 2015; 73(10):916-23. PubMed ID: 25985728
[TBL] [Abstract][Full Text] [Related]
4. Effect of polymer-free TiO2 stent coated with abciximab or alpha lipoic acid in porcine coronary restenosis model.
Lim KS; Jeong MH; Bae IH; Park JK; Park DS; Kim JM; Kim JH; Kim HS; Kim YS; Jeong HY; Song SJ; Yang EJ; Cho DL; Sim DS; Park KH; Hong YJ; Ahn Y
J Cardiol; 2014 Nov; 64(5):409-18. PubMed ID: 24852847
[TBL] [Abstract][Full Text] [Related]
5. Polymer-free biolimus a9-coated stent demonstrates more sustained intimal inhibition, improved healing, and reduced inflammation compared with a polymer-coated sirolimus-eluting cypher stent in a porcine model.
Tada N; Virmani R; Grant G; Bartlett L; Black A; Clavijo C; Christians U; Betts R; Savage D; Su SH; Shulze J; Kar S
Circ Cardiovasc Interv; 2010 Apr; 3(2):174-83. PubMed ID: 20407114
[TBL] [Abstract][Full Text] [Related]
6. Comparative preclinical evaluation of a polymer-free sirolimus-eluting stent in porcine coronary arteries.
Sperling C; Waliszewski MW; Kherad B; Krackhardt F
Ther Adv Cardiovasc Dis; 2019; 13():1753944719826335. PubMed ID: 30803407
[TBL] [Abstract][Full Text] [Related]
7. Differences in tissue characterization of restenotic neointima between sirolimus-eluting stent and bare-metal stent: integrated backscatter intravascular ultrasound analysis for in-stent restenosis.
Ando H; Amano T; Takashima H; Harada K; Kitagawa K; Suzuki A; Kunimura A; Shimbo Y; Harada K; Yoshida T; Kato B; Uetani T; Kato M; Matsubara T; Kumagai S; Yoshikawa D; Isobe S; Ishii H; Murohara T
Eur Heart J Cardiovasc Imaging; 2013 Oct; 14(10):996-1001. PubMed ID: 23341147
[TBL] [Abstract][Full Text] [Related]
8. [Stents coated with sirolimus and anti-CD34 antibody can optimize the performance of sirolimus-eluting stents].
Song XT; Zhu HG; Yang XS; Yuan F; Lü SZ
Zhonghua Xin Xue Guan Bing Za Zhi; 2011 Nov; 39(11):997-1004. PubMed ID: 22336451
[TBL] [Abstract][Full Text] [Related]
9. Influence of drug-eluting stent on inflammation during restenosis in a porcine coronary model.
Ge H; Zhou Y; Hanying M; Liu L; Nie X; Wang Z; Wang F
Acta Cardiol; 2010 Feb; 65(1):31-5. PubMed ID: 20306887
[TBL] [Abstract][Full Text] [Related]
10. Five-year follow-up of the Sirolimus-Eluting Stents vs Vascular Brachytherapy for Bare Metal In-Stent Restenosis (SISR) trial.
Alli OO; Teirstein PS; Satler L; Sketch MH; Popma JJ; Mauri L; Wang HP; Schleckser PA; Cohen SA; Holmes DR;
Am Heart J; 2012 Mar; 163(3):438-45. PubMed ID: 22424015
[TBL] [Abstract][Full Text] [Related]
11. Investigation of long-term implantation of BuMA stent in a porcine coronary model.
Chen M; Wang XG; Zheng B; Peng HY; Zhang XY; Zhang B; Huo Y
Chin Med J (Engl); 2012 Nov; 125(22):4083-7. PubMed ID: 23158147
[TBL] [Abstract][Full Text] [Related]
12. Histopathological comparison of biodegradable polymer and permanent polymer based sirolimus eluting stents in a porcine model of coronary stent implantation.
Koppara T; Joner M; Bayer G; Steigerwald K; Diener T; Wittchow E
Thromb Haemost; 2012 Jun; 107(6):1161-71. PubMed ID: 22535188
[TBL] [Abstract][Full Text] [Related]
13. Anti-inflammatory effect of abciximab-coated stent in a porcine coronary restenosis model.
Hong YJ; Jeong MH; Lee SR; Hong SN; Kim KH; Park HW; Kim JH; Kim W; Ahn Y; Cho JG; Park JC; Kang JC
J Korean Med Sci; 2007 Oct; 22(5):802-9. PubMed ID: 17982226
[TBL] [Abstract][Full Text] [Related]
14. One-year results of the CRISTAL Trial, a randomized comparison of cypher sirolimus-eluting coronary stents versus balloon angioplasty for restenosis of drug-eluting stents.
Chevalier B; Moulichon R; Teiger E; Brunel P; Metzger JP; Pansieri M; Carrie D; Stoll HP; Wittebols K; Spaulding C; Fajadet J;
J Interv Cardiol; 2012 Dec; 25(6):586-95. PubMed ID: 22994863
[TBL] [Abstract][Full Text] [Related]
15. Paclitaxcel-coated balloon plus bare metal stent vs. sirolimus-eluting stent in de novo lesions: an IVUS study.
Fischer D; Scheller B; Schäfer A; Klein G; Böhm M; Clever Y; Cremers B
EuroIntervention; 2012 Aug; 8(4):450-5. PubMed ID: 22917728
[TBL] [Abstract][Full Text] [Related]
16. Firebird and cypher sirolimus-eluting stents and bare metal stents in treatment of very long coronary lesions.
Fan L; Chen LL; Lin CG; Peng YF; Zheng XC; Luo YK; Zhang FL; Chen JH; Yan XP; Huang ZR
Chin Med J (Engl); 2008 Aug; 121(16):1518-23. PubMed ID: 18982862
[TBL] [Abstract][Full Text] [Related]
17. [Experimental study of Mytrolimus-eluting stents on preventing restenosis in porcine coronary model].
Qiu H; Gao RL; Tang ZR; Meng L; Zhao H; Ruan YM; Zhao H; Yang YJ; Chen JL; Chen ZJ
Zhonghua Xin Xue Guan Bing Za Zhi; 2005 Jun; 33(6):561-4. PubMed ID: 16053797
[TBL] [Abstract][Full Text] [Related]
18. Randomized trial of paclitaxel- versus sirolimus-eluting stents for treatment of coronary restenosis in sirolimus-eluting stents: the ISAR-DESIRE 2 (Intracoronary Stenting and Angiographic Results: Drug Eluting Stents for In-Stent Restenosis 2) study.
Mehilli J; Byrne RA; Tiroch K; Pinieck S; Schulz S; Kufner S; Massberg S; Laugwitz KL; Schömig A; Kastrati A;
J Am Coll Cardiol; 2010 Jun; 55(24):2710-6. PubMed ID: 20226618
[TBL] [Abstract][Full Text] [Related]
19. 5-year clinical outcomes after sirolimus-eluting stent implantation insights from a patient-level pooled analysis of 4 randomized trials comparing sirolimus-eluting stents with bare-metal stents.
Caixeta A; Leon MB; Lansky AJ; Nikolsky E; Aoki J; Moses JW; Schofer J; Morice MC; Schampaert E; Kirtane AJ; Popma JJ; Parise H; Fahy M; Mehran R
J Am Coll Cardiol; 2009 Sep; 54(10):894-902. PubMed ID: 19712798
[TBL] [Abstract][Full Text] [Related]
20. Comparison of dextran-based sirolimus-eluting stents and PLA-based sirolimus-eluting stents in vitro and in vivo.
Lee SY; Bae IH; Park DS; Jang EJ; Shim JW; Lim KS; Park JK; Sim DS; Jeong MH
J Biomed Mater Res A; 2017 Jan; 105(1):301-310. PubMed ID: 27615559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
